Comment on “A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children”

被引:0
作者
Jiajing Wang [1 ]
机构
[1] Southern Medical University,Department of Anesthesiology, Nanfang Hospital
[2] The key Laboratory of Precision Anesthesia & perioperative Organ Protection,Department of Anesthesiology, Zengcheng Campus Nanfang Hospital
[3] Southern Medical University,undefined
关键词
Dexmedetomidine; Esketamine; Children; Sample size; Sedation;
D O I
10.1186/s13049-025-01403-5
中图分类号
学科分类号
摘要
This comment critiques a trial comparing intranasal dexmedetomidine (DEX) and esketamine (sKET) for pediatric procedural sedation. Despite a large effect size, the small sample (n = 29) likely caused false-negative results (p = 0.09), necessitating larger trials. Safety concerns (e.g., aspiration risk), unaddressed long-term psychological outcomes, and limited pharmacokinetic data (delayed DEX onset, prolonged duration) challenge clinical applicability. Future studies should integrate objective measures and long-term follow-up.
引用
收藏
相关论文
empty
未找到相关数据